Literature DB >> 31884429

Propofol versus Fentanyl for Sedation in Pediatric Bronchoscopy: A Randomized Controlled Trial.

P K G Gunathilaka1, Kana Ram Jat1, Jhuma Sankar1, Rakesh Lodha1, S K Kabra2.   

Abstract

OBJECTIVE: To compare propofol and fentanyl to induce conscious sedation in children undergoing flexible bronchoscopy. STUDY
DESIGN: Randomized controlled trial.
SETTING: Pediatric Pulmonology division at a tertiary care center in Delhi, India. PARTICIPANTS: Children aged 3-15 years who underwent flexible bronchoscopy. INTERVENTION: Children received either intravenous propofol 1 mg/kg administered as a slow bolus over 1 minute followed by 2 mg/kg/hour infusion, or intravenous Fentanyl 2 µg/kg administered as a slow bolus over one minute. OUTCOMES: Primary outcome was time to achieve conscious sedation (Ramsay score 3). Secondary outcomes were need for adjuvant midazolam, physician satisfaction, level of cough, recovery features, and side-effects in the groups.
RESULTS: 53 children (propofol 27, fentanyl 26) were enrolled in the study. The mean (SD) time taken to achieve Ramsay score 03 was lower in propofol than fentanyl [15.7 (4.4) s vs 206 (55) s, P<0.001]. Propofol arm had significantly higher physician satisfaction, less requirement of adjuvant midazolam, less coughing and faster regain of full consciousness. There was no difference in drug side-effects between the groups.
CONCLUSIONS: Propofol has a shorter sedation induction time, less coughing during procedure, less recovery time, and better physician satisfaction compared to fentanyl for flexible bronchoscopy in children.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31884429

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  1 in total

1.  Comparison of the Effects of Esketamine/Propofol and Sufentanil/Propofol on the Incidence of Intraoperative Hypoxemia during Bronchoscopy: Protocol for a Randomized, Prospective, Parallel-Group Trial.

Authors:  Xiao Huang; Pan Ai; Changwei Wei; Yuan Sun; Anshi Wu
Journal:  J Clin Med       Date:  2022-08-05       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.